Johnson & Johnson (JNJ.N) said on Thursday it has reached an agreement with the U.S. administration under President Donald Trump to lower drug prices for Americans in exchange for exemptions from U.S. tariffs, Reuters reported.

The company said the joint agreement addresses the requests laid out by President Trump to the pharmaceutical industry and provides its products with tariff relief, though specific terms of the deal were not disclosed, according to a statement from J&J.

In December, the Trump administration announced that it had reached similar agreements with nine major pharmaceutical companies to reduce medicine costs for Medicaid beneficiaries and cash-paying consumers, aiming to align U.S. drug prices with those in other wealthy nations, Reuters noted.

J&J also announced on Thursday plans to build two new manufacturing facilities in North Carolina and Pennsylvania, Reuters reported, highlighting the company’s investment in domestic production alongside the pricing agreement.